Earnings Feed
Start Free
Home/Filings/4/0001209191-11-016275
4//SEC Filing

FRANCO RICHARD A 4

Accession 0001209191-11-016275

CIK 0001009356other
View on SEC.govCompany Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:22 PM ET

Size

11.2 KB

Accession

0001209191-11-016275

Insider Transaction Report

Form 4
Period: 2011-03-04
SALIX PHARMACEUTICALS LTDSLXP
FRANCO RICHARD A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2011-03-04$17.63/sh+15,000$264,450→ 49,334 total
  • Exercise/Conversion

    Common Stock

    2011-03-04$18.87/sh+22,500$424,649→ 71,834 total
  • Exercise/Conversion

    Option to Buy Common Stock

    2011-03-04−15,000→ 0 total
    Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)
  • Exercise/Conversion

    Option to Buy Common Stock

    2011-03-04−22,500→ 0 total
    Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    4,500
Footnotes (1)
  • [F1]Options are 100% vested.

Documents

1 file

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

→
Entity typeother

Related Parties

1
  • filerCIK 0001212673

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:22 PM ET
Size
11.2 KB
View on SEC.gov